MAC-话题@MedSci

#MAC#

655篇内容 | 2503人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1996473, encodeId=09e719964e372, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Front Pharmacol：不同PCSK9抑制剂，哪个降脂力量更强？, objectType=article, longId=726544, objectId=1e53e265444e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e53e265444e, replyNumber=0, likeNumber=89, createdTime=2022-08-28, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e53e265444e, moduleTitle=Front Pharmacol：不同PCSK9抑制剂，哪个降脂力量更强？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e53e265444e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996482, encodeId=07b81996482e9, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Front Pharmacol：益生菌联合中药治疗溃疡性结肠炎的疗效和安全性, objectType=article, longId=728791, objectId=250fe2879102, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=250fe2879102, replyNumber=0, likeNumber=116, createdTime=2022-07-06, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=250fe2879102, moduleTitle=Front Pharmacol：益生菌联合中药治疗溃疡性结肠炎的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=250fe2879102)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996516, encodeId=40e71996516fc, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Clin Pharmacol Ther：血管紧张素转换酶抑制剂与胰岛素促泌剂同时使用与严重低血糖的风险, objectType=article, longId=739474, objectId=f928e39474c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f928e39474c7, replyNumber=0, likeNumber=81, createdTime=2023-01-13, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f928e39474c7, moduleTitle=Clin Pharmacol Ther：血管紧张素转换酶抑制剂与胰岛素促泌剂同时使用与严重低血糖的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f928e39474c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996502, encodeId=4f451996502c8, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=J Ethnopharmacol：瘀血痹片通过抑制LOX/Ras/Raf-1信号抑制实验性类风湿关节炎血管生成, objectType=article, longId=735939, objectId=e78fe35939ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e78fe35939ca, replyNumber=0, likeNumber=107, createdTime=2022-10-04, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e78fe35939ca, moduleTitle=J Ethnopharmacol：瘀血痹片通过抑制LOX/Ras/Raf-1信号抑制实验性类风湿关节炎血管生成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e78fe35939ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996464, encodeId=e0a9199646474, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Biomed Pharmacother：养血解毒汤通过调节外泌体HSP70分泌介导的TLR4/NF-κB信号通路对银屑病样病变的保护作用, objectType=article, longId=724178, objectId=040de2417805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=040de2417805, replyNumber=0, likeNumber=71, createdTime=2022-10-05, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=040de2417805, moduleTitle=Biomed Pharmacother：养血解毒汤通过调节外泌体HSP70分泌介导的TLR4/NF-κB信号通路对银屑病样病变的保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=040de2417805)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996460, encodeId=fec519964608a, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle= Front Pharmacol：龙藤汤通过调节2型固有淋巴细胞促进胶原诱导关节炎小鼠滑膜炎症的消退, objectType=article, longId=301521, objectId=2b0d3015217c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b0d3015217c, replyNumber=0, likeNumber=96, createdTime=2022-09-20, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b0d3015217c, moduleTitle= Front Pharmacol：龙藤汤通过调节2型固有淋巴细胞促进胶原诱导关节炎小鼠滑膜炎症的消退, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b0d3015217c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996455, encodeId=aea719964555a, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=European Radiology：CCTA预测斑块进展和主要不良心脏事件(MACE)究竟有何优点和挑战？, objectType=article, longId=300781, objectId=d915300e8164, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d915300e8164, replyNumber=0, likeNumber=83, createdTime=2022-12-13, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d915300e8164, moduleTitle=European Radiology：CCTA预测斑块进展和主要不良心脏事件(MACE)究竟有何优点和挑战？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d915300e8164)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996497, encodeId=41a8199649ed1, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Eur Rev Med Pharmacol Sci：老年人创伤性脑损伤前服用VK拮抗剂或DOACs是否会影响其结局？, objectType=article, longId=732947, objectId=823ae3294744, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=823ae3294744, replyNumber=0, likeNumber=82, createdTime=2023-06-29, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=823ae3294744, moduleTitle=Eur Rev Med Pharmacol Sci：老年人创伤性脑损伤前服用VK拮抗剂或DOACs是否会影响其结局？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=823ae3294744)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996490, encodeId=ca05199649051, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Front Pharmacol：中医药治疗阿尔茨海默病合并骨质疏松症的广阔前景, objectType=article, longId=730934, objectId=3b82e309345b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b82e309345b, replyNumber=0, likeNumber=90, createdTime=2022-10-19, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b82e309345b, moduleTitle=Front Pharmacol：中医药治疗阿尔茨海默病合并骨质疏松症的广阔前景, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b82e309345b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996465, encodeId=95d219964650e, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Front Pharmacol：疏肝和胃汤改善慢性应激模型大鼠抑郁、焦虑样行为——调节盲肠菌群和抑制NLRP3炎症小体减轻盲肠黏膜损伤, objectType=article, longId=724608, objectId=7c5de2460814, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c5de2460814, replyNumber=0, likeNumber=127, createdTime=2023-02-24, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c5de2460814, moduleTitle=Front Pharmacol：疏肝和胃汤改善慢性应激模型大鼠抑郁、焦虑样行为——调节盲肠菌群和抑制NLRP3炎症小体减轻盲肠黏膜损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c5de2460814)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996500, encodeId=010519965000b, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Front Pharmacol：2号肺痹方通过GSK-3β/mTOR途径诱导自噬改善肺纤维化, objectType=article, longId=735825, objectId=b143e358258f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b143e358258f, replyNumber=0, likeNumber=141, createdTime=2023-01-11, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b143e358258f, moduleTitle=Front Pharmacol：2号肺痹方通过GSK-3β/mTOR途径诱导自噬改善肺纤维化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b143e358258f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996462, encodeId=15e2199646271, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Rhizen Pharmaceuticals AG在AACR 2022公布其差异化的PARP和DHODH抑制剂项目的数据, objectType=article, longId=724127, objectId=b5ebe2412785, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5ebe2412785, replyNumber=0, likeNumber=87, createdTime=2022-09-26, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5ebe2412785, moduleTitle=Rhizen Pharmaceuticals AG在AACR 2022公布其差异化的PARP和DHODH抑制剂项目的数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5ebe2412785)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996467, encodeId=3539199646efd, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=DOM:2型糖尿病患者早期和持续稳定的血糖控制与主要不良心血管事件(MACE)的减少相关, objectType=article, longId=724839, objectId=0f64e24839a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f64e24839a9, replyNumber=0, likeNumber=104, createdTime=2022-05-17, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f64e24839a9, moduleTitle=DOM:2型糖尿病患者早期和持续稳定的血糖控制与主要不良心血管事件(MACE)的减少相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f64e24839a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996503, encodeId=064e1996503f8, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle= J Ethnopharmacol：桂枝茯苓丸在女性子宫肌瘤中的随机双盲试验, objectType=article, longId=736391, objectId=5cc2e36391f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5cc2e36391f3, replyNumber=0, likeNumber=126, createdTime=2022-10-27, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5cc2e36391f3, moduleTitle= J Ethnopharmacol：桂枝茯苓丸在女性子宫肌瘤中的随机双盲试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5cc2e36391f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996518, encodeId=5ed21996518be, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=J Ethnopharmacol：丹灯通脑胶囊对脑微血管内皮细胞的保护作用, objectType=article, longId=739446, objectId=c183e3944624, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c183e3944624, replyNumber=0, likeNumber=70, createdTime=2022-10-26, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c183e3944624, moduleTitle=J Ethnopharmacol：丹灯通脑胶囊对脑微血管内皮细胞的保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c183e3944624)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996477, encodeId=514319964e783, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Front Pharmacol:舒泻一号汤通过IL-6/JAK2/STAT3信号通路减轻慢性轻度不可预见性应激诱导的肝损伤, objectType=article, longId=728080, objectId=069ce2808010, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=069ce2808010, replyNumber=0, likeNumber=72, createdTime=2023-04-07, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=069ce2808010, moduleTitle=Front Pharmacol:舒泻一号汤通过IL-6/JAK2/STAT3信号通路减轻慢性轻度不可预见性应激诱导的肝损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=069ce2808010)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996507, encodeId=3f9b199650e50, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Front Pharmacol：新见解！持续使用ARB药物可降低急性肾损伤患者死亡风险, objectType=article, longId=737481, objectId=513ee374817a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=513ee374817a, replyNumber=0, likeNumber=111, createdTime=2023-07-03, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=513ee374817a, moduleTitle=Front Pharmacol：新见解！持续使用ARB药物可降低急性肾损伤患者死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=513ee374817a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996492, encodeId=d1ec199649256, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=Front Pharmacol：具有伤口愈合特性的中药, objectType=article, longId=730957, objectId=c16de30957f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c16de30957f7, replyNumber=0, likeNumber=92, createdTime=2022-10-30, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c16de30957f7, moduleTitle=Front Pharmacol：具有伤口愈合特性的中药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c16de30957f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996501, encodeId=3766199650170, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=J Ethnopharmacol：结合网络药理学和转录组学验证研究木防己汤预防肺癌的疗效及机制, objectType=article, longId=735334, objectId=481fe35334ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=481fe35334ff, replyNumber=0, likeNumber=0, createdTime=2023-07-07, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=481fe35334ff, moduleTitle=J Ethnopharmacol：结合网络药理学和转录组学验证研究木防己汤预防肺癌的疗效及机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=481fe35334ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1996506, encodeId=12311996506e6, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, objectTitle=J Ethnopharmacol：综合系统药理学分析和实验验证，揭示中药娑罗子对炎症性肠病的作用机制, objectType=article, longId=736624, objectId=494ee366241e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=494ee366241e, replyNumber=0, likeNumber=80, createdTime=2023-03-22, rootId=0, userName=yb6560, userId=4b65161, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=494ee366241e, moduleTitle=J Ethnopharmacol：综合系统药理学分析和实验验证，揭示中药娑罗子对炎症性肠病的作用机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=494ee366241e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

MAC

2020-05-29

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Front Pharmacol：不同PCSK9抑制剂，哪个降脂力量更强？

2022-08-28

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Front Pharmacol：益生菌联合中药治疗溃疡性结肠炎的疗效和安全性

2022-07-06

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Clin Pharmacol Ther：血管紧张素转换酶抑制剂与胰岛素促泌剂同时使用与严重低血糖的风险

2023-01-13

yb6560 (审核中...)

前往app查看评论内容

#MAC#

J Ethnopharmacol：瘀血痹片通过抑制LOX/Ras/Raf-1信号抑制实验性类风湿关节炎血管生成

2022-10-04

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Biomed Pharmacother：养血解毒汤通过调节外泌体HSP70分泌介导的TLR4/NF-κB信号通路对银屑病样病变的保护作用

2022-10-05

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Front Pharmacol：龙藤汤通过调节2型固有淋巴细胞促进胶原诱导关节炎小鼠滑膜炎症的消退

2022-09-20

yb6560 (审核中...)

前往app查看评论内容

#MAC#

European Radiology：CCTA预测斑块进展和主要不良心脏事件(MACE)究竟有何优点和挑战？

2022-12-13

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Eur Rev Med Pharmacol Sci：老年人创伤性脑损伤前服用VK拮抗剂或DOACs是否会影响其结局？

2023-06-29

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Front Pharmacol：中医药治疗阿尔茨海默病合并骨质疏松症的广阔前景

2022-10-19

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Front Pharmacol：疏肝和胃汤改善慢性应激模型大鼠抑郁、焦虑样行为——调节盲肠菌群和抑制NLRP3炎症小体减轻盲肠黏膜损伤

2023-02-24

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Front Pharmacol：2号肺痹方通过GSK-3β/mTOR途径诱导自噬改善肺纤维化

2023-01-11

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Rhizen Pharmaceuticals AG在AACR 2022公布其差异化的PARP和DHODH抑制剂项目的数据

2022-09-26

yb6560 (审核中...)

前往app查看评论内容

#MAC#

DOM:2型糖尿病患者早期和持续稳定的血糖控制与主要不良心血管事件(MACE)的减少相关

2022-05-17

yb6560 (审核中...)

前往app查看评论内容

#MAC#

J Ethnopharmacol：桂枝茯苓丸在女性子宫肌瘤中的随机双盲试验

2022-10-27

yb6560 (审核中...)

前往app查看评论内容

#MAC#

J Ethnopharmacol：丹灯通脑胶囊对脑微血管内皮细胞的保护作用

2022-10-26

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Front Pharmacol:舒泻一号汤通过IL-6/JAK2/STAT3信号通路减轻慢性轻度不可预见性应激诱导的肝损伤

2023-04-07

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Front Pharmacol：新见解！持续使用ARB药物可降低急性肾损伤患者死亡风险

2023-07-03

yb6560 (审核中...)

前往app查看评论内容

#MAC#

Front Pharmacol：具有伤口愈合特性的中药

2022-10-30

yb6560 (审核中...)

前往app查看评论内容

#MAC#

J Ethnopharmacol：结合网络药理学和转录组学验证研究木防己汤预防肺癌的疗效及机制

2023-07-07

yb6560 (审核中...)

前往app查看评论内容

#MAC#

J Ethnopharmacol：综合系统药理学分析和实验验证，揭示中药娑罗子对炎症性肠病的作用机制

2023-03-22

科室
- - 订阅+
  - 更多科室
工具
服务